LEMAITRE VASCULAR INC LMAT
LEMAITRE VASCULAR INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($31.19); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
LEMAITRE VASCULAR INC trades at about 32.6× earnings — below its 10-year norm (10-year range 21.1×–50.7×, median 41.3×).
Shaded band = 10-year range (21.1×–50.7×); dot = today's 32.6×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 71.5% | 68.6% | 65.7% | 64.9% | 65.7% | 65.4% | 68.1% | 70.0% | 70.1% | 70.6% |
| Operating margin | 27.2% | 23.8% | 19.0% | 16.6% | 23.6% | 22.3% | 18.1% | 26.7% | 20.9% | 18.3% |
| Net margin | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% | 16.4% | 15.3% | 21.7% | 17.0% | 11.9% |
| FCF margin | — | — | — | — | — | — | — | — | — | 15.8% |
| Return on assets | 9.4% | 8.0% | 8.7% | 6.6% | 9.2% | 8.4% | 9.5% | 15.0% | 13.6% | 10.4% |
| Return on equity | 14.7% | 13.1% | 10.1% | 7.7% | 10.6% | 12.3% | 12.1% | 17.6% | 15.6% | 12.1% |
| Current ratio | 12.89 | 13.14 | 6.51 | 6.39 | 6.41 | 3.75 | 4.42 | 4.76 | 6.09 | 5.63 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.